[LRMR] YoY Quarter Result on 30-Sep-2021 [#Q3]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
12-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -33.28%
YoY- -63.57%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -15,499 -9,064 -8,320 -16,805 -10,274 -8,628 -15,067 0.47%
Tax 0 -76 -193 0 -50 -4,286 0 -
NP -15,499 -9,064 -8,127 -16,805 -10,274 -8,628 -15,067 0.47%
Tax Rate - - - - - - - -
Total Cost 15,499 9,064 8,127 16,805 10,274 8,628 15,067 0.47%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.24 -0.21 -0.37 -0.92 -0.64 -0.94 -4.11 -37.68%
EPS Diluted -0.24 -0.21 -0.37 -0.92 -0.64 -0.94 -4.11 -37.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.